1. Clinical characteristics of relapsed ovarian cancer patients with striking response to the bevacizumab at first relapse. (October 2019) Authors: Kose, F.; Alemdaroglu, S.; Mertsoylu, H.; Besen, A.; Guler, O.; Simsek, S.; Erbay, G.; Onal, C.; Celik, H. Journal: Leukemia research Issue: Volume 85(2019)Supplement 1 Page Start: S34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗